(From left) CRM chief executive officer Dr Akhmal Yusof, Dr Dzulkefly, Health director-general Datuk Dr Muhammad Radzi Abu Hassan and Roche (M) Sdn Bhd country medical director Dr Wendy Tay at the announcement.
HOSPITAL Umum Sarawak (SGH) in Kuching has been selected by Roche Pharma-ceuticals as its site for a first-in-human (FIH) clinical trial.
Roche is the first top multinational company to bring its FIH trials under a rheumatology indication to Malaysia, a testament to the country’s growing clinical trial capabilities.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
